1996
DOI: 10.1111/j.1749-6632.1996.tb39075.x
|View full text |Cite
|
Sign up to set email alerts
|

Protection against Impairment of Memory and Immunoreactivity in Senescence‐Accelerated Mice by Acidic Fibroblast Growth Factora

Abstract: Subcutaneous injection of aFGF once a week into senescence-accelerated mice (SAM)P8 was begun at 3 weeks after birth and continued for 10 months. Saline was injected as a control. Learning and memory and cellular immunological functions in the aFGF group were enhanced significantly, while those of the saline group deteriorated. 1. The number of cholinergic neurons was decreased by less than 20% and choline acetyltransferase activity in individual neurons in the medical septum which send monosynaptic terminals … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

1998
1998
2013
2013

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(9 citation statements)
references
References 0 publications
0
9
0
Order By: Relevance
“…Indeed, NMDAR receptor density was significantly elevated in the CA1 region of hippocampus after NSC transplantation. This result is consistent with previous observations that s.c. injection of neurotrophic factors, which correlated with the increasing immunoreactivity of NMDAR, could alleviate cognitive deficits in SAMP8 [24].…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, NMDAR receptor density was significantly elevated in the CA1 region of hippocampus after NSC transplantation. This result is consistent with previous observations that s.c. injection of neurotrophic factors, which correlated with the increasing immunoreactivity of NMDAR, could alleviate cognitive deficits in SAMP8 [24].…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, administration of FGF-2 either intraventricular or subcutaneous appears to increase neurogenesis and NSCs proliferation in the SEZ and SGZ of both young and aged mice [118, 119]. Furthermore, FGF has been shown to protect against memory impairment in senescence-accelerated mice, a murine model of aging [120, 121]. It might be relevant to point out that at least one strain of senescent-accelerated mice with an increased neurological senescent phenotype resembling human aging has been shown to have a 50% deletion of its FGF-1 gene, leading to the complete absence of the protein in the brain.…”
Section: Fgf Signaling In Ectodermal Stem Cells and Tissuesmentioning
confidence: 99%
“…Continuous aFGF s.c. injection once a week into senescence-accelerated mice (SAMP8), which is a useful animal model to study aging or age-associated disorders due to its inherited aging phenotype, increases density of muscarinic and aFGF receptor in hippocampal neurons, and the LTP in hipocampal slice preparation is significantly facilitated (19).…”
Section: Introductionmentioning
confidence: 99%